日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Homologous recombination deficiency and hemizygosity drive resistance in breast cancer

同源重组缺陷和半合子状态是乳腺癌耐药性的驱动因素

Safonov, Anton; Lee, Minna; Brown, David N; Boscolo Bielo, Luca; Mehine, Miika; Bandlamudi, Chaitanya; O'Leary, Ben; Shao, Hong; Vicente, Laia; Muldoon, Daniel; Zhu, Allen; Ros, Susana; Marra, Antonio; Selenica, Pier; Bieche, Ivan; Wubbenhorst, Bradley; Ferraro, Emanuela; Courtois, Laura; El Botty, Rania; Ahmed, Mehnaj; Moiso, Enrico; An, Julia Ah-Reum; Donoghue, Mark T A; Will, Marie; Pareja, Fresia; Nizialek, Emily; Lukashchuk, Natalia; Sofianopoulou, Eleni; Liu, Yuan; Huang, Xin; Chappey, Colombe; Staniszewska, Anna D; Ross, Dara; Mandelker, Diana; Ladanyi, Marc; Schultz, Nikolaus; Berger, Michael F; Scaltriti, Maurizio; Reis-Filho, Jorge S; Li, Bob T; Offit, Kenneth; Norton, Larry; Shen, Ronglai; Maxwell, Kara N; Couch, Fergus; Domchek, Susan M; Marangoni, Elisabetta; Shah, Sohrab; Albertella, Mark R; Serra, Violeta; Weigelt, Britta; Solit, David B; Nathanson, Katherine L; Robson, Mark E; Turner, Nicholas C; Chandarlapaty, Sarat; Razavi, Pedram

p53 Drives Lung Cancer Regression through a TSC2/TFEB-dependent Senescence Program.

p53 通过 TSC2/TFEB 依赖的衰老程序驱动肺癌消退。

Wang Mengxiong, Bieging-Rolett Kathryn T, Kaiser Alyssa M, Brady Colleen A, Lockhart John H, Ferreira Sofia, Nguyen Kha T, Rajeevan Arati, Evans Simone A, Zhao Tianyu, Raj Nitin, Elkrief Arielle, Tischfield Sam E, Ladanyi Marc, Ozawa Michael G, Bui Nam Q, Chen Christopher T, Flores Elsa R, Attardi Laura D

Publisher Correction: APOBEC3 mutagenesis drives therapy resistance in breast cancer

出版商更正:APOBEC3 突变驱动乳腺癌治疗耐药性

Gupta, Avantika; Gazzo, Andrea; Selenica, Pier; Safonov, Anton; Pareja, Fresia; da Silva, Edaise M; Brown, David N; Shao, Hong; Zhu, Yingjie; Patel, Juber; Blanco-Heredia, Juan; Stefanovska, Bojana; Carpenter, Michael A; Chen, Yanjun; Vegas, Isabella; Pei, Xin; Frosina, Denise; Jungbluth, Achim A; Ladanyi, Marc; Curigliano, Giuseppe; Weigelt, Britta; Riaz, Nadeem; Powell, Simon N; Razavi, Pedram; Harris, Reuben S; Reis-Filho, Jorge S; Marra, Antonio; Chandarlapaty, Sarat

RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236

RRAS 和 RRAS2 突变是肺癌中常见的致癌驱动因素,并且对泛 RAS 抑制剂 RMC-6236 敏感。

Pfeil, Alexander J; Zhang, Tom; Cheng, Ryan; Mattar, Marissa S; Gomez Marti, Juan Luis; Gili, Leo; Lai, Rachel; Khodos, Inna; Master, Rohan P; Dix, Jenna-Marie; Gazzo, Andrea; Arbour, Kathryn C; de Stanchina, Elisa; Febres-Aldana, Christopher A; Ladanyi, Marc; Yang, Soo-Ryum; Somwar, Romel

Primitive neuronal component is a frequent finding among IDH-mutant astrocytomas with RB1 alterations

原始神经元成分是伴有RB1改变的IDH突变型星形细胞瘤的常见发现。

Slocum, Cheyanne C; Benhamida, Jamal K; Eckert, Scott; Gedvilaite, Erika; Ptashkin, Ryan; Tabar, Viviane; Young, Robert J; Ladanyi, Marc; Mellinghoff, Ingo K; Rosenblum, Marc K; Brannon, A Rose; Hickman, Richard; Bale, Tejus A

Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer.

对肿瘤抑制基因双等位基因失活的泛癌分析表明,KEAP1 合子性是肺癌的预测性生物标志物

Zucker Mark, Perry Maria A, Gould Samuel I, Elkrief Arielle, Safonov Anton, Thummalapalli Rohit, Mehine Miika, Chakravarty Debyani, Brannon A Rose, Ladanyi Marc, Razavi Pedram, Donoghue Mark T A, Murciano-Goroff Yonina R, Grigoriadis Kristiana, McGranahan Nicholas, Jamal-Hanjani Mariam, Swanton Charles, Chen Yuan, Shen Ronglai, Chandarlapaty Sarat, Solit David B, Schultz Nikolaus, Berger Michael F, Chang Jason, Schoenfeld Adam J, Sánchez-Rivera Francisco J, Reznik Ed, Bandlamudi Chaitanya

Chromothripsis-Mediated Small Cell Lung Carcinoma

染色体碎裂介导的小细胞肺癌

Rekhtman, Natasha; Tischfield, Sam E; Febres-Aldana, Christopher A; Lee, Jake June-Koo; Chang, Jason C; Herzberg, Benjamin O; Selenica, Pier; Woo, Hyung Jun; Vanderbilt, Chad M; Yang, Soo-Ryum; Xu, Fei; Bowman, Anita S; da Silva, Edaise M; Noronha, Anne Marie; Mandelker, Diana L; Mehine, Miika; Mukherjee, Semanti; Blanco-Heredia, Juan; Orgera, John J; Nanjangud, Gouri J; Baine, Marina K; Aly, Rania G; Sauter, Jennifer L; Travis, William D; Savari, Omid; Moreira, Andre L; Falcon, Christina J; Bodd, Francis M; Wilson, Christina E; Sienty, Jacklynn V; Manoj, Parvathy; Sridhar, Harsha; Wang, Lu; Choudhury, Noura J; Offin, Michael; Yu, Helena A; Quintanal-Villalonga, Alvaro; Berger, Michael F; Ladanyi, Marc; Donoghue, Mark T A; Reis-Filho, Jorge S; Rudin, Charles M

Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy.

对致癌MET融合基因的泛癌分析揭示了对MET靶向治疗具有不同敏感性的不同致病基因组亚群

Febres-Aldana Christopher A, Vojnic Morana, Odintsov Igor, Zhang Tom, Cheng Ryan, Beach Catherine Z, Lu Daniel, Mattar Marissa S, Gazzo Andrea M, Gili Leo, Harshan Manju, Ameri Ali, Machnicki Stephen, Xiao Xiuying, Lockwood William W, Zhou Xiao-Yan, Yao Qianlan, Drilon Alexander, Rekhtman Natasha, Shah Nameeta, Li Anqi, Liu Zebing, Yang Soo-Ryum, Davare Monika A, Ladanyi Marc, Somwar Romel

APOBEC3 mutagenesis drives therapy resistance in breast cancer

APOBEC3突变导致乳腺癌治疗耐药

Gupta, Avantika; Gazzo, Andrea; Selenica, Pier; Safonov, Anton; Pareja, Fresia; da Silva, Edaise M; Brown, David N; Shao, Hong; Zhu, Yingjie; Patel, Juber; Blanco-Heredia, Juan; Stefanovska, Bojana; Carpenter, Michael A; Chen, Yanjun; Vegas, Isabella; Pei, Xin; Frosina, Denise; Jungbluth, Achim A; Ladanyi, Marc; Curigliano, Giuseppe; Weigelt, Britta; Riaz, Nadeem; Powell, Simon N; Razavi, Pedram; Harris, Reuben S; Reis-Filho, Jorge S; Marra, Antonio; Chandarlapaty, Sarat

Genetic Ancestry-Based Differences in Biomarker-Based Eligibility for Precision Oncology Therapies

基于遗传祖先的差异对基于生物标志物的精准肿瘤治疗资格的影响

Arora, Kanika; Suehnholz, Sarah P; Zhang, Hongxin; Ostrovnaya, Irina; Kundra, Ritika; Nandakumar, Subhiksha; Nissan, Moriah H; Brannon, A Rose; Bandlamudi, Chaitanya; Ladanyi, Marc; Drilon, Alexander; Brown, Carol L; Solit, David B; Schultz, Nikolaus; Berger, Michael F; Chakravarty, Debyani